HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roger F Martin Selected Research

Neoplasms (Cancer)

10/2021An approach to assessing the contribution of the high LET effect in strategies for Auger endoradiotherapy.
1/2020Cancer Radiotherapy: Understanding the Price of Tumor Eradication.
1/2019Radiation Therapy Modulates DNA Repair Efficiency in Peripheral Blood Mononuclear Cells of Patients With Non-Small Cell Lung Cancer.
11/2018A Bayesian Approach for Prediction of Patient Radiosensitivity.
12/2016Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
11/2016The quest to exploit the Auger effect in cancer radiotherapy - a reflective review.
11/2016Strand breakage by decay of DNA-bound 124I provides a basis for combined PET imaging and Auger endoradiotherapy.
1/2016Potential strategies to ameliorate risk of radiotherapy-induced second malignant neoplasms.
2/2014Mobilization of viable tumor cells into the circulation during radiation therapy.
6/2011γH2AX foci as a measure of DNA damage: a computational approach to automatic analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roger F Martin Research Topics

Disease

13Neoplasms (Cancer)
10/2021 - 11/2004
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 12/2012
1Lymphoma (Lymphomas)
11/2016
1Carcinogenesis
01/2016
1Infections
09/2015
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
06/2012
1Acoustic Neuroma (Acoustic Neurinoma)
06/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2006
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2006
1Phototoxic Dermatitis (Phototoxicity)
11/2006
1Photosensitivity Disorders (Photodermatitis)
06/2006

Drug/Important Bio-Agent (IBA)

4DNA (Deoxyribonucleic Acid)IBA
10/2021 - 11/2004
3LigandsIBA
11/2016 - 06/2006
2Transferrin (beta 2 Transferrin)IBA
11/2016 - 11/2006
1Peptides (Polypeptides)IBA
11/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
1VitaminsIBA
01/2016
1AntioxidantsIBA
01/2016
1Somatostatin Receptors (Somatostatin Receptor)IBA
12/2012
1ErbB Receptors (EGF Receptor)IBA
11/2006
1Monoclonal AntibodiesIBA
11/2006
1Furocoumarins (Furanocoumarins)IBA
11/2006
1Photosensitizing Agents (Photosensitizers)IBA
11/2006
1A-Form DNA (A-DNA)IBA
11/2006

Therapy/Procedure

9Radiotherapy
01/2020 - 10/2010
3Therapeutics
10/2021 - 11/2004
1Hematopoietic Stem Cell Transplantation
09/2015
1Aftercare (After-Treatment)
06/2012
1Photochemotherapy (Photodynamic Therapy)
11/2006
1Phototherapy (Light Therapy)
11/2006